We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual out... LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit. Show more
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that...
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired non-executive employees...
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees...
44 ALLY® Adaptive Cataract Treatment Systems were placed in 2023, significantly exceeding the target of 30, increasing the ALLY installed base to 54 and a backlog of 9 additional systems as of...
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted seven newly-hired non-executive employees...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.04 | -1.26582278481 | 3.16 | 3.6016 | 2.951 | 58819 | 3.12617839 | CS |
| 4 | -0.26 | -7.69230769231 | 3.38 | 3.6016 | 2.67 | 44751 | 3.17106236 | CS |
| 12 | -1.8 | -36.5853658537 | 4.92 | 5.3 | 2.67 | 44251 | 3.80079922 | CS |
| 26 | 0.94 | 43.119266055 | 2.18 | 5.3 | 1.8 | 37551 | 3.46696628 | CS |
| 52 | 0.42 | 15.5555555556 | 2.7 | 5.3 | 1.8 | 30895 | 3.44718935 | CS |
| 156 | -3.86 | -55.3008595989 | 6.98 | 8.98 | 1.8 | 21879 | 4.88352666 | CS |
| 260 | -0.04 | -1.26582278481 | 3.16 | 12.71 | 1.8 | 28362 | 6.21652839 | CS |
PonkenPlonken
2 weeks ago
crj0540
3 years ago
Inspector121
4 years ago
cantgetmyname
4 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
